Glatiramer: FDA adverse event reports
65,310 FDA FAERS reports mention Glatiramer. 30,534 reports have a serious outcome flag.
Reported reactions
- Injection Site Pain: 5,648 reports
- Multiple Sclerosis Relapse: 5,525 reports
- Drug Ineffective: 4,433 reports
- Injection Site Reaction: 3,778 reports
- Fatigue: 3,560 reports
- Multiple Sclerosis: 3,459 reports
- Dyspnoea: 3,174 reports
- Injection Site Erythema: 2,866 reports
- Fall: 2,721 reports
- Injection Site Mass: 2,379 reports
- Gait Disturbance: 2,261 reports
- Pain: 2,216 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.